bmiMD’s Four Price Tiers Compared: When Prepaying Actually Pays Off

bmiMD sells the same compounded semaglutide at four different prices: $99, $109, $119 or $129 a month. The only variable is how long you commit. That $30 spread sounds trivial until you multiply it across a year of treatment — $360 on semaglutide, and a full $480 on tirzepatide, where the tiers run $139 to $179. For a medication most people take for many months, picking the wrong tier is one of the more expensive small mistakes in weight-loss telehealth.

But the cheap tier has a catch: the $99 rate requires prepaying $1,188 for twelve months up front. Prepaid money is locked money, and GLP-1 therapy does not work out for everyone — side effects, plateaus and life changes all end treatments early. So the real question is not “which tier is cheapest” but “at what point does prepaying actually pay off.” That question has a precise mathematical answer, and we are going to compute it.

The Four Tiers on the Table

Commitment	Semaglutide /mo	Tirzepatide /mo	Semaglutide, 12-mo total	Tirzepatide, 12-mo total
Month-to-month	$129	$179	$1,548	$2,148
3-month plan	$119	$159	$1,428	$1,908
6-month plan	$109	$149	$1,308	$1,788
12-month plan	$99	$139	$1,188	$1,668

Every tier includes the provider visit and unlimited messaging, and bmiMD backs the intake with a 100% money-back promise if you are not approved for treatment. A subscribe-and-save option shaves a further 10% off. The service claims 80,000+ members and holds a 4.4-star Trustpilot rating across roughly 867 reviews — decent social proof that the tiers themselves are not a bait-and-switch. So the comparison here is purely between your own four options.

Round 1: The Break-Even Math

A prepaid plan beats month-to-month only if you stay in treatment long enough for the discount to outrun the lock-in. Divide each plan’s upfront cost by the $129 month-to-month rate and you get the break-even point in months:

Semaglutide plan	Upfront cost	Break-even vs $129/mo	Verdict
3-month ($119/mo)	$357	2.8 months	Wins almost immediately
6-month ($109/mo)	$654	5.1 months	Wins if you finish the plan
12-month ($99/mo)	$1,188	9.3 months	Needs a long runway to win

Read that middle column carefully. The 3-month plan breaks even before it even ends — quit after your three months and you have still paid less than three month-to-month cycles would have cost. The 12-month plan is the opposite animal: stop at month six and your $1,188 works out to $198 per month, dramatically worse than simply paying $129 as you went. The deepest discount only becomes real at month ten.

Round verdict: the 3-month tier is the only one that is mathematically almost risk-free. The 12-month tier is a bet on your own persistence.

Round 2: Semaglutide Tiers vs Tirzepatide Tiers

The tirzepatide ladder is steeper. The gap between month-to-month and the annual plan is $40 per month instead of $30, so commitment is rewarded more generously — $480 a year — but the break-even math also shifts. The tirzepatide 12-month plan costs $1,668 upfront, which against the $179 monthly rate breaks even at 9.3 months, the same proportional threshold as semaglutide. The practical difference is absolute dollars at risk: abandoning a tirzepatide annual plan at month six strands roughly $594 of value versus about $414 on semaglutide.

There is also a sequencing insight here. Many bmiMD members start on semaglutide (the cheaper molecule) and only step up to tirzepatide if results stall. If that is even remotely your plan, do not prepay a year of semaglutide — a mid-year molecule switch turns your discount into a write-off. Shorter tiers preserve the option to change horses.

Round verdict: the bigger the monthly price, the shorter the plan you should prepay. Tirzepatide users have more dollars at stake and should favor the 3- or 6-month tiers even more strongly.

Round 3: The Fine Print That Moves the Numbers

Two caveats belong in any honest version of this math. First, compounded GLP-1s are not FDA-approved products. The active ingredients appear in FDA-approved drugs, but compounded versions themselves are prepared under the FDA’s pharmacy compounding rules rather than going through their own approval process — that is what makes the $99-a-month price possible, and it is a trade-off you should knowingly accept, not stumble into. Everything runs under prescription and provider oversight, which is the correct structure, but the regulatory distinction is real.

Second, read the refund terms before prepaying. bmiMD’s 100% money-back guarantee applies if you are not approved — it is not a satisfaction guarantee for month seven of a twelve-month plan. Assume prepaid funds are committed once treatment starts, and size your tier accordingly. The stack-on 10% subscribe-and-save discount, by contrast, is low-risk: it compounds your savings without extending your lock-in.

Round verdict: the fine print does not change the rankings, but it hardens the rule — never prepay further than you can confidently see yourself staying.

Which Tier Should You Pick?

First-timers: take the 3-month plan at $119/$159. You get an immediate discount over month-to-month, a break-even you clear before the plan ends, and a natural checkpoint to evaluate side effects and results before committing deeper.

Restarters and veterans: if you have already tolerated a GLP-1 well and know you respond, the 12-month tier is genuinely the best deal on the menu — $99 a month is at the very low end of the compounded-semaglutide market, and your personal risk of quitting early is the one variable you actually know.

The undecided: the 6-month plan is the honest middle: a $20 monthly discount, a 5.1-month break-even, and half the locked capital of the annual plan.

Almost nobody: month-to-month. It only makes sense as a one-or-two-month trial if you are unusually uncertain — and even then, the 3-month plan’s break-even means the trial premium is small.

FAQs

Is the $99/month price real? Yes, but it is an average of a prepaid commitment: you pay $1,188 once, covering twelve months. Nothing is billed monthly at that tier.

What happens if I am not approved? bmiMD refunds 100% of your payment if the provider does not approve you for treatment, which removes the biggest risk of prepaying before your consultation.

Are there options besides semaglutide and tirzepatide? Yes — microdose GLP-1 programs, metformin, MIC+B12 injections and a naltrexone/bupropion/B6 combination, which give the provider somewhere to route you if injectable GLP-1s are a poor fit.

Why is compounded medication so much cheaper? Compounded drugs skip the branded manufacturer entirely; pharmacies prepare them under FDA compounding rules. Cheaper, legal, prescription-gated — but not FDA-approved as products, which is the honest asterisk on every price in this article.

Final Verdict

bmiMD’s tier system rewards exactly one behavior: accurately predicting your own commitment. The 3-month plan is the rational default — it beats month-to-month almost from day one and costs you only $20 a month against the theoretical best price. The 12-month plan’s $360 to $480 in annual savings is real, but only for people past month nine, so treat it as a renewal decision, not a starting one. Start at three months, learn how your body responds, then buy the long plan with information instead of optimism. That is how prepaying actually pays off.